Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4357-4364

  Sanders, Jennifer L ^a   Chattopadhyay, Naibedya ^a   Kifor, Olga ^a   Yamaguchi, Toru ^a   Butters, Robert R ^a   Brown, Edward M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE METASTASIS; BREAST CANCER; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 0034526037     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7849     Document Type: Article

References (41)

1. Cancer statistics, 1994
2. Bone metastases and breast cancer
3. Skeletal complications of malignancy
4. Parathyroid hormone-related protein and bone metastases
5. Metastatic bone disease: Clinical and therapeutic aspects
6. Detection of bone metastases in breast cancer by 18 FDG PET: Differing metabolic activity in osteoblastic and osleolytic lesions
7. Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer
8. Parathyroid hormone-related protein (PTHrP) in malignancy: Hypercalcemia bon metastases
9. Localization of parathyroid hormone-related protein mRNA in breast cancer metastasis: Increased incidence in bone as compared with other sites
10. Localization of parathyroid hormone-related protein mRNA expression and metastatic lesions by in situ hybridization
11. Parathyroid hormone related protein and skeletal morbidity in breast cancer
12. Breast tumor cell lines from pleural effusions
13. PTHrP expression by breast cancer cells enhance osteolytic bone metastases in vivo
14. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
15. Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones
16. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
17. Microlectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts
18. Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression
19. Parathyroid-hormone-related peptide in hematologic malignancies
20. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro
21. 2+ sensor and parathyroid hormone-related protein
22. High extracellular calcium increases the production of parathyroid hormone-like activity by cultured leydig cells associated with humoral hypercalcemia
23. (2+)-sensing receptor from bovine parathyroid
24. Identification and localization of the extracellular calcium-sensing receptor in human breast
25. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs
26. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism
27. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of boviae parathyroid cells
28. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
29. Expression of extracellular calcium-sensing receptor by human lens epithelial cells
30. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium
31. Expression and signal transduction of calcium-sensing receptors in cartilage and bone
32. Calcimimetics with potent and selective activity on the parathyroid calcium receptor
33. The calcimimetic R-467 potentiates insulin secretion in pancreatic β cells by activation of a nonspecific cation channel
34. Cancer and bone
35. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment
36. Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphonate (APD)
37. Treatment of skeletal disease in breast cancer with clodronate
38. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
39. Functional calcium-sensing receptor expression in ovarian surface epithelial cells
40. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide
41. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor